HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma.

AbstractBACKGROUND:
The aim of this study was to investigate the prognostic value of cell proliferation (Ki-67 antigen) and DNA content in patients resected for distal bile duct carcinoma (DBDC).
METHODS:
Formalin-fixed tumor specimens of 35 patients with resected DBDC and a long-term clinical follow-up were analyzed. MIB-1 antibody was used for Ki-67 antigen detection to determine the proportion of proliferating cells. DNA content was measured using flow cytometry.
RESULTS:
A significant correlation was found between a low MIB-1 index (<20%) and survival (P <.05). Of the 35 tumor specimens, 34 specimens were evaluable by flow cytometry: 22 carcinomas were diploid (65%), and 12 were aneuploid (35%). The median DNA index of aneuploid tumors was 1.36 (range, 1.09 to 1.76). No correlation of DNA-ploidy with survival time was found.
CONCLUSION:
In contrast to DNA-ploidy pattern, Ki-67 antigen expression showed prognostic significance in resectable DBDC. A Ki-67 positive ratio of > or =20% was associated with decreased survival time.
AuthorsA M Rijken, A Umezawa, T M van Gulik, A Bosma, M M Polak, G J Offerhaus, H Obertop, D J Gouma
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 5 Issue 8 Pg. 699-705 (Dec 1998) ISSN: 1068-9265 [Print] United States
PMID9869516 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
  • Ki-67 Antigen
Topics
  • Adult
  • Aged
  • Bile Duct Neoplasms (pathology, surgery)
  • Cholangiocarcinoma (pathology, surgery)
  • DNA, Neoplasm (analysis)
  • Female
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen (analysis)
  • Male
  • Middle Aged
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: